Helen Chalk

Helen Chalk is an experienced professional in the field of clinical operations, having held significant leadership positions at several biotechnology firms. As Vice President of Clinical Operations at Mythic Therapeutics, Inc., Mersana Therapeutics, and Anokion, Chalk has demonstrated expertise in advancing clinical programs. Previously, Chalk served as Senior Director of Clinical Operations at TESARO, Inc., and as Director and Clinical Program Lead at Vertex Pharmaceuticals. A graduate of Loughborough University, Chalk earned a Bachelor of Science with Honors in Human Biology from 1990 to 1994.